BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 1:19:00 PM | Browse: 1501 | Download: 1490
 |
Received |
|
2012-10-22 18:48 |
|
Peer-Review Started |
|
2012-10-23 08:51 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2012-11-03 23:26 |
|
Revised |
|
2012-12-29 00:21 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-01-23 17:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-01-24 08:01 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-03-27 21:08 |
|
Publish the Manuscript Online |
|
2013-04-14 19:05 |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Salvatore D'Angelo, Mario Secondulfo, Raffaele De Cristofano and Paolo Sorrentino |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salvatore D'Angelo, MD, Liver Unit, Clinical and Experimental Hepatology, S.G. Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy. sadangelo@aosgmoscati.av.it
|
| Key Words |
Entecavir; Hepatocellular carcinoma; Hepatitis B virus; Liver function; Sorafenib |
| Core Tip |
|
| Publish Date |
2013-04-14 19:05 |
| Citation |
D’Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma? World J Gastroenterol 2013; 19(14): 2141-2143 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i14/2141.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i14.2141 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
